Seoul, South Korea

Haeng Ran Seo

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Institut Pasteur Korea, Korea Institute of Radiological & Medical Sciences. Active years: 2026.

USPTO Granted Patents = 1 


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Haeng Ran Seo: Innovator in Medical Applications of 2-Methoxyestradiol Derivatives

Introduction

Haeng Ran Seo is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical science, particularly through his innovative work on 2-methoxyestradiol derivatives. His research focuses on the treatment and prevention of liver and lung fibrosis, showcasing his commitment to advancing medical knowledge and therapeutic options.

Latest Patents

Haeng Ran Seo holds a patent for "2-methoxyestradiol derivatives and medical uses thereof." This invention relates to novel derivatives of 2-Methoxyestradiol and their medical applications. The derivatives are particularly useful for treating or preventing liver or lung fibrosis. The patent also outlines methods for administering effective amounts of these derivatives to achieve therapeutic benefits.

Career Highlights

Throughout his career, Haeng Ran Seo has worked with esteemed institutions such as Institut Pasteur Korea and the Korea Institute of Radiological & Medical Sciences. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Haeng Ran Seo has collaborated with Inhee Choi, further enhancing the impact of his research and innovations in the medical field.

Conclusion

Haeng Ran Seo's work on 2-methoxyestradiol derivatives represents a significant advancement in the treatment of fibrosis-related conditions. His contributions to medical science highlight the importance of innovation in developing effective therapies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…